Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds JP Morgan Upgrades Solid Biosciences to Neutral

JP Morgan Upgrades Solid Biosciences to Neutral

JP Morgan analyst Anupam Rama upgrades Solid Biosciences (NASDAQ:SLDB) from Underweight to Neutral.

byBenzinga Newsdesk

September 30, 2022

1 minute read

JP Morgan analyst Anupam Rama upgrades Solid Biosciences (NASDAQ:SLDB) from Underweight to Neutral.

MingZhu Logistics Hldgs’ Debt Overview

By Benzinga Insights

December 27, 2:03 PM

Over the past three months, shares of MingZhu Logistics Hldgs Inc. (NASDAQ:YGMZ) decreased by 40.09%. Before having a look at the importance of debt, let's look at how much debt MingZhu Logistics Hldgs has.

YGMZ

Analyst Ratings

Analyst Ratings for CytomX Therapeutics

By Benzinga Insights

July 7, 4:28 PM

Analysts have provided the following ratings for CytomX Therapeutics (NASDAQ:CTMX) within the last quarter:

CTMX

‘Judge Denies Media Request To Allow Cameras At Donald Trump Hearing’ – UPI

By Benzinga Newsdesk

June 13, 11:58 AM

https://www.upi.com/Top_News/US/2023/06/13/miami-donald-trump-courtoom-media-blocked/2611686668422/?utm_source=dlvr.it&utm_medium=twtA Florida judge denied a request to allow cameras, photographers and media groups

SPY

BMO Capital Maintains Outperform on Boralex, Lowers Price Target to C$50

By Benzinga Newsdesk

November 21, 10:01 AM

BMO Capital analyst Ben Pham maintains Boralex (TSX:BLX) with a Outperform and lowers the price target from C$53 to C$50.

TSX:BLX

JP Morgan Upgrades Solid Biosciences to Neutral

Related Posts

MingZhu Logistics Hldgs’ Debt Overview

Analyst Ratings for CytomX Therapeutics

‘Judge Denies Media Request To Allow Cameras At Donald Trump Hearing’ – UPI

BMO Capital Maintains Outperform on Boralex, Lowers Price Target to C$50